| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |